Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.99 USD
+0.23 (5.98%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $3.98 -0.01 (-0.25%) 4:34 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.76 |
EPS Last Quarter | -0.95 |
Last EPS Surprise | -3.26% |
ABR | 1.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.19 |
Next Year | -3.25 |
EPS (TTM) | -1.98 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 26.28M | 9.27M | 80.28M | 69.69M |
# of Estimates | 6 | 5 | 7 | 6 |
High Estimate | 63.85M | 13.27M | 214.86M | 204.86M |
Low Estimate | 5.00M | 5.00M | 28.01M | 18.79M |
Year ago Sales | 10.41M | 16.92M | 153.73M | 80.28M |
Year over Year Growth Est. | 152.43% | -45.22% | -47.78% | -13.19% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.76 | -0.91 | -3.19 | -3.25 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | -0.99 | -1.01 | -3.99 | -3.61 |
High Estimate | -0.09 | -0.80 | -0.76 | -0.74 |
Low Estimate | -1.04 | -1.06 | -4.10 | -4.86 |
Year ago EPS | -0.64 | -0.81 | -1.91 | -3.19 |
Year over Year Growth Est. | -18.75% | -12.35% | -67.02% | -1.89% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.76 | -0.91 | -3.19 | -3.25 |
7 Days Ago | -0.76 | -0.91 | -3.19 | -3.25 |
30 Days Ago | -0.76 | -0.91 | -3.19 | -3.25 |
60 Days Ago | -0.74 | -0.91 | -3.19 | -3.25 |
90 Days Ago | -0.64 | -0.90 | -3.15 | -3.05 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.76 | -0.91 | -3.19 | -3.25 |
Zacks Consensus Estimate | -0.76 | -0.91 | -3.19 | -3.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.95 | 0.42 | -0.81 | -0.64 | NA |
Estimate | -0.92 | -0.82 | -0.76 | -0.73 | NA |
Difference | -0.03 | 1.24 | -0.05 | 0.09 | 0.31 |
Surprise | -3.26% | 151.22% | -6.58% | 12.33% | 38.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more